SMAD2 and renal fibrosis: Blockade of downstream targets of the TGF-β/Smad signaling pathway inhibits both renal fibrosis and inflammation by blocking both the Smad2/3 and NF-κB signaling pathways in rat remnant kidney and UUO models [41,42,43].